Skip to content

Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents

Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00308256
Enrollment
77
Registered
2006-03-29
Start date
2006-03-31
Completion date
2011-08-31
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type1 diabetes;, nurse-counselling;, adolescent

Brief summary

The incidence of type 1 diabetes is increasing in France. A recent cross sectional study has shown that in France, only 15% of children and 26% of adults had HbA1c\<7%. Adolescents seem to need particularly a better metabolic control. Working Hypothesis: We hypothesized that a stricter control of glycaemia by nurse-counselling could probably improve metabolic control in adolescents with type 1 diabetes. Objectives: To show that nurse-counselling may improve levels of patient satisfaction. Methodology: The main criterion is the patient acceptance of diabetes measured by an analogical visual scale rated from 0 (I cope very well with my diabetes, I cope very badly with my diabetes) to 10 cm. The scale will be measured every quarter within 12 months follow-up. We wish to improve patient's appreciation by 10 mm, near to I cope very well with my diabetes. This is a randomised parallel group study with 36 subjects in each group. During the follow-up, the routine follow-up group will continue its routine care. The complementary follow-up group will be called by nurses every 15 days and consult monthly. HbA1c is the secondary criterion and will be measured every 3 months. The total study duration is 18 months including 6 months for the recruitment and 12 months for the patients follow-up

Interventions

BEHAVIORALnurse-counselling

Phone calls performed by nurse 15 days after each monthly visit

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 13 to 18 years with a type1 diabetes diagnosed at least one year earlier, * HbA1c rate \> 8 %.

Exclusion criteria

* HbA1c \< 8 %; * patients participating in another study

Design outcomes

Primary

MeasureTime frame
Patient's acceptance of the disease evaluated by an analogical visual scale rating12 months

Secondary

MeasureTime frame
Glycaemic equilibrium by measuring the rate of glycosylated haemoglobin12 months
Number of diabetic acidosis having required hospitalization,12 months
Episodes number of severe hypoglycaemia having required an intervention of a third party or a hospitalization.12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026